EuroQol sponsors ISPOR Europe 2024 symposium on using HRQoL data from children and youth to strengthen HTA: What are the challenges? How can we improve current practice?

By Esther Daane | November 7, 2024

Attending ISPOR Europe 2024 in Barcelona this month? Interested in knowing more about the challenges currently posed by measuring and valuing health in children and youth with a focus on HTA? Come along to this symposium, sponsored by EuroQol, to hear a range of perspectives from HTA, industry, and academia, on this very topical subject.…

Read More

Four-year EuroQol initiative to help accelerate COVID-19 related research ends

By Esther Daane | November 5, 2024

Over the duration of the COVID-19 pandemic emergency, the EuroQol Research Foundation offered study-specific licenses free of charge to commercial customers wishing to use EQ-5D instruments in studies aimed at testing COVID-19 treatments or diagnostic tools. During this period, numerous commercial organisations undertook COVID-19 related research around the world using EQ-5D instruments – with EuroQol…

Read More

EQ-5D-Y-3L User Guide update

By Esther Daane | June 14, 2024

An updated EQ-5D-Y-3L User Guide is now available on the EuroQol website.  Changes include: renaming the EQ-5D-Y to the EQ-5D-Y-3L ahead of the launch of a new version of a new EQ-5D youth instrument during 2024 (EQ-5D-Y-5L, which provides five response levels of severity to questions in the descriptive system); revisions to clarify recommended age…

Read More

EuroQol Experimental Instrument Registration Form

By Esther Daane | June 13, 2024

The EuroQol Office introduced the EuroQol Experimental Instrument Registration Form on the EuroQol website on the 1st of June to streamline all incoming requests for the use of Experimental versions. The registration form applies to requests to use the EQ-HWB, EQ-HWB-S, EQ-TIPS and EQ-5D-Y-5L which are not publicly available yet and are only shared with…

Read More